Researcher Profile Form First National Pediatric Brain Tumor Research Meeting March 9, 2025 - Jerusalem
Researcher: Prof. Rachela Popovtzer
Current Role & Affiliation
Title/Position: Prof. Rachela Popovtzer is Head of the Laboratory of Nanotheranostics for Personalized Medicine in the Faculty of Engineering, at Bar Ilan University
Institution: Bar Ilan University
Email: rachela.popovtzer@biu.ac.il
Phone: 050-9010226
Prof. Popovtzer leads a research group developing design principles for nanoparticles to be used both as molecular imaging contrast agents and for targeted therapy.
Research Focus
nanoparticles
CRISPR in rare genetic disorders
Multimodal nanoparticles for non-invasive tracking of therapeutic stem cells for muscle regeneration
Current Projects Related to Pediatric Brain Tumors
nanoparticles use in imaging and targeted therapy
What You Can Offer Potential Collaborators
Extensive knowledge and experience in nano- bioengineering and nanoparticles
Ongoing studies re nanoparticles’ use in imaging and targeted therapy
patented nanoparticles (Nanocarry.LTD)
Keywords
bioengineering , nanoparticles, exosomes, liposomes, targeted therapy, imaging
Recent Relevant Publications
1. Anaki A,et.al. Popovtzer R.Impact of synthesis methods on the functionality of antibody-conjugated gold nanoparticles for targeted therapy.Nanoscale Adv. 2024 Sep 4;6(21):5420-9.
2. Gal O, et.al. Antibody Delivery into the Brain by Radiosensitizer Nanoparticles for Targeted Glioblastoma Therapy.J Nanotheranostics. 2022 Sep 30;3(4):177-188. doi: 10.3390/jnt3040012.
3. Betzer O, et.al. Multifunctional nanoprobe for real-time in vivo monitoring of T cell activation. Nanomedicine. 2022 Nov;46:102596. doi: 10.1016/j.nano.2022.102596. Epub 2022 Aug 27.
Brief Bio
Prof. Rachela Popovtzer is Head of the Laboratory of Nanotheranostics for Personalized Medicine in the Faculty of Engineering, and a member of the Institute of Nanotechnology and Advanced Materials, at Bar Ilan University. She has previously served as Vice Dean and head of the Bioengineering Track in the Faculty of Engineering, and was a visiting Professor at Memorial Sloan Kettering Cancer Center, NY.
Prof Popovtzer is the founder and CTO of Nanocarry biotech company
